Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01742182 · ClinicalTrials.gov registry record · NA
Circadian Rhythms and Sleep-Wake Cycles in Parkinson's Disease
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT01742182: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01742182 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01742182, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
Disruption of sleep and alertness is one of the most disabling non-motor symptoms of Parkinson's disease (PD). Mechanisms leading to impaired sleep and alertness in PD are not well understood, and treatment options remain limited. The proposed research will examine markers of the circadian system, sleepiness and sleep quality in PD patients and healthy controls. Further, the project will examine effects of bright light exposure on circadin function, sleep and alertness in PD.
Interventions
- OTHER Light exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2012-06 |
| Est. Completion | 2018-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01742182
The ClinicalTrials.gov registry entry for NCT01742182 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Light exposure is the first listed.
NCT01742182 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01742182 about?
NCT01742182 is a clinical study titled "Circadian Rhythms and Sleep-Wake Cycles in Parkinson's Disease". Disruption of sleep and alertness is one of the most disabling non-motor symptoms of Parkinson's disease (PD). Mechanisms leading to impaired sleep and alertness in PD are not well understood, and treatment options remain limited. The proposed research will examine markers of the circadian system, s...
What is the current status of trial NCT01742182?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2012-06. Estimated completion is 2018-06.
What interventions are being tested in trial NCT01742182?
The interventions under investigation include: Light exposure (OTHER).
Who is sponsoring clinical trial NCT01742182?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.